BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27050170)

  • 61. Out-of-field contributions for IMRT and volumetric modulated arc therapy measured using gafchromic films and compared to calculations using a superposition/convolution based treatment planning system.
    Van den Heuvel F; Defraene G; Crijns W; Bogaerts R
    Radiother Oncol; 2012 Oct; 105(1):127-32. PubMed ID: 22300610
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigating neutron activated contrast agent imaging for tumor localization in proton therapy: a feasibility study for proton neutron gamma-x detection (PNGXD).
    Van Delinder KW; Crawford D; Zhang T; Khan R; Gräfe JL
    Phys Med Biol; 2020 Jan; 65(3):035005. PubMed ID: 31851952
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Sensitivity of different dose scoring methods on organ-specific neutron dose calculations in proton therapy.
    Jarlskog CZ; Paganetti H
    Phys Med Biol; 2008 Sep; 53(17):4523-32. PubMed ID: 18677040
    [TBL] [Abstract][Full Text] [Related]  

  • 64. OPTIMIZATION OF AN ADDITIONAL COLLIMATOR IN A BEAM DELIVERY SYSTEM FOR REDUCTION OF THE SECONDARY NEUTRON EXPOSURE IN PASSIVE CARBON-ION THERAPY.
    Komori M; Takeuchi A; Niwa M; Harada T; Oguchi H
    Radiat Prot Dosimetry; 2019 Jul; 184(1):28-35. PubMed ID: 30339247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
    Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ambient neutron and photon dose equivalent H*(10) around a pencil beam scanning proton therapy facility.
    Sharma DS; Patro KC; Manthala Padannayel N; Arjunan M; Krishnan G; Thiyagarajan R; Chilukuri S; Jalali R
    Br J Radiol; 2019 Oct; 92(1102):20190382. PubMed ID: 31287739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of Neutron Production in Passively Scattered Ion-Beam Therapy.
    Heo S; Yoo S; Song Y; Kim E; Shin J; Han S; Jung W; Nam S; Lee R; Lee K; Cho S
    Radiat Prot Dosimetry; 2017 Jul; 175(3):297-303. PubMed ID: 27885084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
    Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An accelerator-based epithermal neutron beam design for BNCT and dosimetric evaluation using a voxel head phantom.
    Lee DJ; Han CY; Park SH; Kim JK
    Radiat Prot Dosimetry; 2004; 110(1-4):655-60. PubMed ID: 15353726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neutron H*(10) inside a proton therapy facility: comparison between Monte Carlo simulations and WENDI-2 measurements.
    De Smet V; Stichelbaut F; Vanaudenhove T; Mathot G; De Lentdecker G; Dubus A; Pauly N; Gerardy I
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):417-21. PubMed ID: 24255173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Physical and biological factors determining the effective proton range.
    Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M
    Med Phys; 2013 Nov; 40(11):111716. PubMed ID: 24320424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peripheral photon and neutron doses from prostate cancer external beam irradiation.
    Bezak E; Takam R; Marcu LG
    Radiat Prot Dosimetry; 2015 Dec; 167(4):591-601. PubMed ID: 25564673
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Clatterbridge high-energy neutron therapy facility: measurements of beam parameters for clinical use.
    Shaw JE; Bonnett DE; Blake SW
    Br J Radiol; 1988 Jan; 61(721):47-53. PubMed ID: 3126849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
    Titt U; Zheng Y; Vassiliev ON; Newhauser WD
    Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
    [TBL] [Abstract][Full Text] [Related]  

  • 75. AAA and PBC calculation accuracy in the surface build-up region in tangential beam treatments. Phantom and breast case study with the Monte Carlo code PENELOPE.
    Panettieri V; Barsoum P; Westermark M; Brualla L; Lax I
    Radiother Oncol; 2009 Oct; 93(1):94-101. PubMed ID: 19541380
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modulation of lateral positions of Bragg peaks via magnetic fields inside cancer patients: Toward magnetic field modulated proton therapy.
    Shao W; Tang X; Bai Y; Geng C; Shu D; Gong C; Chen D
    Med Phys; 2017 Oct; 44(10):5325-5338. PubMed ID: 28696514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neutron fluence-to-dose conversion coefficients for embryo and fetus.
    Chen J; Meyerhof D; Vlahovich S
    Radiat Prot Dosimetry; 2004; 110(1-4):693-8. PubMed ID: 15353732
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The risk of developing a second cancer after receiving craniospinal proton irradiation.
    Newhauser WD; Fontenot JD; Mahajan A; Kornguth D; Stovall M; Zheng Y; Taddei PJ; Mirkovic D; Mohan R; Cox JD; Woo S
    Phys Med Biol; 2009 Apr; 54(8):2277-91. PubMed ID: 19305036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Out-of-Field Doses Produced by a Proton Scanning Beam Inside Pediatric Anthropomorphic Phantoms and Their Comparison With Different Photon Modalities.
    Knežević Ž; Stolarczyk L; Ambrožová I; Caballero-Pacheco MÁ; Davídková M; De Saint-Hubert M; Domingo C; Jeleń K; Kopeć R; Krzempek D; Majer M; Miljanić S; Mojżeszek N; Romero-Expósito M; Martínez-Rovira I; Harrison RM; Olko P
    Front Oncol; 2022; 12():904563. PubMed ID: 35957900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.